| Trial ID: | L4543 |
| Source ID: | NCT00315718
|
| Associated Drug: |
Extract From Hintonia Latiflora Bark
|
| Title: |
Long-Term Effects of Sucontral(TM) on Mild and Moderate Cases of Diabetes Mellitus (Type 2)
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes Mellitus, Type 2
|
| Interventions: |
DRUG: Extract from Hintonia latiflora bark
|
| Outcome Measures: |
Primary: HbA1c values | Secondary: Postprandial blood glucose|Fasting blood glucose|General vegetative symptoms|BMI|Liver function tests (ALT, GGT, AP)|Serum lipids (triglycerides, cholesterol, HDL cholesterol)|Adverse drug reactions (narratives)|Blood pressure (systolic/diastolic)
|
| Sponsor/Collaborators: |
Sponsor: Harras Pharma Curarina GmbH
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE3
|
| Enrollment: |
10
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2002-06
|
| Completion Date: |
2005-06
|
| Results First Posted: |
|
| Last Update Posted: |
2006-04-19
|
| Locations: |
Hospital of Trencin, Trencin, SK-91171, Slovakia
|
| URL: |
https://clinicaltrials.gov/show/NCT00315718
|
